COMMUNIQUÉS West-GlobeNewswire

Cyfluent Achieves EHNAC Cloud-Enabled Accreditation

11/09/2018 - 18:14

CEAP accreditation offers a higher level of stakeholder confidence for organizations under competitive pressures to demonstrate the rigor and structure of cloud-enabled platforms and applications ARLINGTON, Va., Sept. [...]

CellAegis annonce l’achèvement de l’inscription de patients à la première étude nord-américaine pour un traitement innovant de la crise cardiaque utilisant le dispositif autoRIC®

11/09/2018 - 18:11

TORONTO, 11 sept. 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (« CellAegis » ou la « Société »), entreprise de dispositifs médicaux qui commercialise des solutions novatrices, non invasives, sûres et rentables pour [...]

OSE Immunotherapeutics Announces Issuance of a European Patent Protecting FR104, CD28-Antagonist Immunotherapy

11/09/2018 - 18:00

The patent covers therapeutic applications of FR104 in Europe in autoimmune diseases, chronic inflammatory diseases and graft applications through 2031 NANTES, France, Sept. 11, 2018 (GLOBE NEWSWIRE) -- OSE [...]

UPDATE: Professor Cosman Redefines Robotic Surgery in Australia

11/09/2018 - 17:15

BRIGHTON, Mich., Sept. 11, 2018 (GLOBE NEWSWIRE) -- FlexDex Inc. is pleased to announce the first surgical procedure performed utilizing the FlexDex ® Needle Driver took place on July 31, 2018 in Australia. Prof. Peter [...]

Predictive Technology Group Announces Opening of New Laboratory Facilities

11/09/2018 - 17:02

SALT LAKE CITY, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC/PINK: PRED), a life-sciences technology company, announces its subsidiary Predictive Biotech has completed phase one of its new [...]

Exagen, Maker of AVISE Testing, Announces First Blood Test for Anti-CarP, a Breakthrough Bio-marker for Rheumatoid Arthritis

11/09/2018 - 16:05

Novel Test Now Available to Aid in Detection and Management of Widespread Debilitating Condition San Diego, CA and Albuquerque, NM, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, the leader in specialty [...]

Radius Health to Present at the Morgan Stanley 16th Annual Global Health Care Conference

11/09/2018 - 15:15

WALTHAM, Mass., Sept. 11, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS) announced today that Jesper Høiland, President and CEO, and Pepe Carmona, Chief Financial Officer of the Company, will present a [...]

CalibreScientific Acquires PhytoTechnology Laboratories, a Leading Provider of Plant Molecular Biology and Plant Tissue Culture Research Products

11/09/2018 - 15:00

LOS ANGELES, Sept. 11, 2018 (GLOBE NEWSWIRE) -- CalibreScientific is pleased to announce that it has completed the acquisition of PhytoTechnology Laboratories, LLC (“PhytoTech Labs“ or the “Company”), a provider of [...]

Q-Centrix Launches Innovative Data Management Initiative Focused on Enabling Hospitals to Keep up with Modern Quality Reporting Demands

11/09/2018 - 14:51

The effort combines data automation technologies, human-centered design, and behavioral economics factors to drive more efficient and cost-effective processes to advance hospitals’ healthcare quality reporting [...]

Marrone Bio Innovations Appoints Jenna Combs as Sales Manager of Northern California Territory

11/09/2018 - 14:31

DAVIS, Calif., Sept. 11, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental [...]

Precision Therapeutics Appoints Dr. Amelia Warner to Scientific Advisory Board

11/09/2018 - 14:30

MINNEAPOLIS, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]

CellAegis Announces Completion of Patient Enrollment in First North American Study for Innovative Heart Attack Therapy Using autoRIC®

11/09/2018 - 14:30

TORONTO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective solutions for [...]

Advanced Proteome Therapeutics Provides Overview of Current Activities and Strategic Objectives

11/09/2018 - 14:30

VANCOUVER, British Columbia, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) , is pleased to provide an overview of current projects prior to [...]

Viveve Submits Investigational Device Exemption to FDA to Conduct LIBERATE-U.S. Trial for Improvement of Stress Urinary Incontinence

11/09/2018 - 14:28

ENGLEWOOD, Colo., Sept. 11, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced submission of an Investigational Device [...]

Vectura Group plc: Interim Results

11/09/2018 - 14:08

This contains inside information Vectura Group plc Vectura regaining momentum with continued inhaled revenue and adjusted EBITDA growth Chippenham, UK - 11 September 2018 : Vectura Group plc (LSE: VEC) ("Vectura" or " [...]

ORYZON receives approval to start ALICE: a Phase IIa clinical trial in AML with Iadademstat (ORY-1001)

11/09/2018 - 14:00

The study will be done in elderly Acute Myeloid Leukemia (AML) patients not eligible for intensive chemotherapy It is the first Phase II study of Iadademstat (ORY-1001) in combination therapy MADRID, Spain and CAMBRIDGE [...]

Tetra Bio-Pharma Accelerates its European Drug Registration Activities

11/09/2018 - 14:00

PPP001 and PPP005 Eligible for Marketing Approval ORLEANS, Ontario, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc . (" Tetra " or the " Corporation ") (TSX VENTURE: TBP) (OTCQB: TBPMF), a global leader in [...]

Atara Biotherapeutics Appoints Cancer Research and Clinical Development Veteran, Roy Baynes, to its Board of Directors

11/09/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., Sept. 11, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]

BioSig Technologies Issues Shareholder Letter

11/09/2018 - 14:00

Highlights include FDA 510(k) clearance and Nasdaq uplisting Santa Monica, CA, Sept. 11, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM, OTCQB:BSGMD) a medical device company developing a proprietary [...]